# US COVID Testing Kit Market > US COVID Testing Kit Market Research Report: Size, Share, Trend Analysis By Types (Immunoassay Test Strips, RT-PCR Assay Kits, Others), By Specimen (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab) and By End Users (Hospitals and Clinics, Diagnostic Laboratories, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.55% - **2024:** $ 19.84 Billion - **2025:** $ 21.34 Billion - **2035:** $ 44.18 Billion - **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), BD (Becton, Dickinson and Company) (US), Siemens Healthineers (DE), Quidel Corporation (US), Cepheid (US), Hologic, Inc. (US), PerkinElmer, Inc. (US) **Report ID:** MRFR/HC/13099-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-covid-testing-kit-market-14626 --- ## Market Summary ## **US COVID Testing Kit Market Overview** As per MRFR analysis, the US COVID Testing Kit Market Size was estimated at 12.04 (USD Billion) in 2023. The US COVID Testing Kit Market Industry is expected to grow from 13.5(USD Billion) in 2024 to 30 (USD Billion) by 2035. The US COVID Testing Kit Market CAGR (growth rate) is expected to be around 7.529% during the forecast period (2025 - 2035). ### **Key US COVID Testing Kit Market Trends Highlighted** The US COVID Testing Kit Market has seen significant shifts driven by the ongoing need for efficient and accessible testing solutions. Key market drivers include the increasing demand for rapid and home-testing kits, as more individuals prefer the convenience of testing at home due to busy lifestyles and ongoing concerns about virus transmission. Additionally, government initiatives to promote widespread testing and vaccination strategies have spurred innovations in testing technology, leading to a surge in the development of more accurate and faster testing kits. Opportunities to be explored include further expansion into underserved populations and remote areas, where access to testing has historically been limited. Companies can capitalize on partnerships with healthcare providers and community organizations to enhance distribution networks, ensuring a broader reach. Moreover, the increasing emphasis on regular testing as part of public health strategies, especially in schools and workplaces, presents a lucrative avenue for growth. Recent trends indicate a shift towards the integration of artificial intelligence in testing processes, helping to streamline operations and enhance the accuracy of results. The use of mobile applications for tracking test results and symptoms has also gained traction. Furthermore, the rise of variant strains of the virus has necessitated ongoing adaptations in testing kit offerings, pushing companies to innovate continuously. Overall, the landscape is evolving rapidly, with a focus on improving accessibility, accuracy, and efficiency in testing solutions across the United States. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US COVID Testing Kit Market Drivers** ### **Increased Demand for Rapid Testing Solutions** The constant evolution and spread of COVID-19 variants in the US have led to an increased demand for rapid testing solutions. According to the Centers for Disease Control and Prevention (CDC), new variants are monitored for their potential impact on public health with approximately 50% of cases being attributed to these variants. Rapid at-home testing kits have become pivotal during surges, allowing individuals to quickly check their status and prevent further spread. The US [COVID Testing Kit](../../../reports/covid-testing-kit-market-9715) Market Industry is seeing a profound shift towards these rapid testing solutions, with government policies facilitating easier access to at-home tests to curb transmission rates and ensure timely identification of cases. These changing dynamics and aggressive responses to new variants have resulted in significant growth in the US COVID Testing Kit Market. ### **Government Initiatives and Funding** Government initiatives and funding play a critical role in bolstering the US COVID Testing Kit Market. The US government has invested heavily in testing programs to control the pandemic's spread, with allocations in billions for COVID-19 testing across communities. The Department of Health and Human Services has emphasized expanding testing capacity, with reports revealing nearly 50 million tests administered weekly during peak times. Such initiatives ensure that testing remains accessible and available, thereby supporting market growth. By partnering with manufacturers for testing kits and expanding distribution channels, the government enables rapid responses to outbreaks and facilitates a robust health infrastructure that positions the US COVID Testing Kit Market for continued expansion. ### **Growing Awareness of Public Health and Safety** There is a rising awareness of public health and safety among the US population which has led to an increase in testing. Data from the American Public Health Association indicate that approximately 70% of Americans consider it essential to get tested for COVID-19 regularly, especially when symptoms appear or after exposure. This heightened awareness drives demand for COVID testing kits, both at home and in public facilities. The increased focus on individual and community health resonates strongly in the US, pushing consumers toward purchasing and utilizing testing kits. Citizens are now more proactive in ensuring their health and safety, which significantly contributes to the growth trajectory of the US COVID Testing Kit Market Industry. ## **US COVID Testing Kit Market Segment Insights** ### **COVID Testing Kit Market Type Insights** The US COVID Testing Kit Market, particularly categorized by Type, showcases a diverse array of products catering to the evolving demands of health and testing protocols during the pandemic. One prominent category within this market is Immunoassay Test Strips, which have gained significant traction due to their ability to provide rapid results, thus facilitating quick decision making in clinical settings and at-home testing environments. These strips leverage antibodies to detect the presence of the virus in blood or other samples, making them essential for routine screening in high-risk populations. In contrast, RT-PCR Assay Kits remain a cornerstone in the arsenal against COVID-19. Known for their accuracy and reliability, these kits utilize a sensitive method to detect virus RNA, making them the gold standard for confirming active infections. The dependence on RT-PCR testing has fostered a robust infrastructure within the United States, with laboratories equipped to manage high-throughput testing, which is crucial for tracking and controlling outbreaks within communities. The category 'Others' encompasses a variety of innovative testing solutions that continue to emerge, including antigen tests and combination tests. These innovations represent significant opportunities in the market, focusing on improving testing efficiency and accessibility. The evolution of testing technologies has been driven by factors such as increased public awareness of COVID-19, regulatory support for rapid diagnostics, and a growing emphasis on personal health management. Moreover, the US COVID Testing Kit Market segmentation reflects profound growth drivers such as heightened government-led public health initiatives, advances in testing technology, and rising investments in healthcare infrastructure. The landscape has not been without challenges, including supply chain issues and the need for continuous updates to testing protocols as variants develop. Nevertheless, the commitment to enhancing testing capabilities positions each type within the market as a vital tool for managing not only COVID-19 but also future public health challenges. Overall, the diversity in the Type segment of the US COVID Testing Kit Market underscores the critical role these products play during and beyond the pandemic. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **COVID Testing Kit Market Specimen Insights** The Specimen segment of the US COVID Testing Kit Market plays a crucial role in the overall methodology of diagnosing COVID-19, leveraging various types of specimens collected from patients. Each choice of specimen, such as Nasopharyngeal Swab, Oropharyngeal Swab, and Nasal Swab, offers unique benefits based on the patient's condition and testing availability. The Nasopharyngeal Swab is often preferred for its high sensitivity in detecting the virus, making it critical for accurate diagnosis. Meanwhile, Oropharyngeal Swabs are significant due to their ease of collection, especially in settings where rapid testing is necessary, while Nasal Swabs are widely adopted for their convenience and comfort for patients. Collectively, these specimens represent a substantial part of the US COVID Testing Kit Market segmentation, as healthcare facilities nationwide utilize these methods to enhance testing efficiency. The growth in testing demand has been spurred by rising infection rates and increasing public health awareness, with these specimens being vital in surveillance and management strategies deployed by the healthcare system across the country. As the market aims to respond to future health challenges, advancements in testing technologies for specimen collection are likely to drive further innovations in the industry. ### **COVID Testing Kit Market End User Insights** The US COVID Testing Kit Market is primarily segmented by End User, reflecting the diverse environments where testing is essential. Hospitals and Clinics represent a critical component, as they provide immediate care and facilitate widespread testing among patients presenting COVID symptoms. Their capacity to manage large patient volumes allows for efficient testing processes, making them a dominant force within this segment. Diagnostic Laboratories play a significant role by offering advanced testing services that ensure accuracy and speed in results, contributing to public health management strategies. This segment is essential in addressing community needs during health crises, thus maintaining the healthcare system's responsiveness. Additionally, the "Others" category encompasses various settings such as pharmacies and urgent care centers, which have emerged as convenient testing sites, further expanding accessibility. Overall, this segmentation demonstrates an adaptive response to the evolving pandemic landscape, with each End User category addressing specific aspects of testing demand and contributing to the overall US COVID Testing Kit Market growth. The emphasis on digital health solutions and at-home testing options also highlights emerging trends within the market, reshaping how testing is approached and executed across these user segments. ## **US COVID Testing Kit Market Key Players and Competitive Insights** The US COVID Testing Kit Market is characterized by a rapidly evolving landscape driven by technological advancements, diverse product offerings, and the ever-increasing demand for accurate and timely testing solutions. As a result of the pandemic, numerous players have emerged, each vying for market share with unique competitive strategies and innovative solutions. This market is marked by an intense focus on research and development, with leading companies prioritizing the enhancement of testing accuracy, speed, and accessibility. Furthermore, the regulatory environment and urgent public health requirements have prompted companies to adapt quickly to meet consumer needs and governmental approvals, creating a highly competitive arena that continues to evolve as the situation surrounding COVID-19 unfolds. Quidel Corporation stands out in the US COVID Testing Kit Market through its strong commitment to innovative testing solutions, emphasizing rapid testing capabilities that cater to the demands of healthcare providers and end-users. With its wide range of products, including antigen and molecular tests, Quidel has established a significant presence in healthcare settings such as hospitals, clinics, and laboratories across the United States. The company has built a reputation for delivering reliable and timely results, enhancing its attractiveness in a market where speed is crucial. Moreover, Quidel’s active engagement with regulatory agencies has enabled it to undergo expedited approvals for its testing devices, solidifying its competitive edge and allowing it to meet urgent market needs effectively. Hologic also commands a prominent position in the US COVID Testing Kit Market by offering cutting-edge diagnostic solutions that address the complexities of the pandemic. The company is known for its molecular diagnostic tests, which deliver high sensitivity and specificity, catering to both symptomatic and asymptomatic individuals. Hologic's commitment to research and development has led to the introduction of novel testing platforms that can integrate COVID testing with other respiratory pathogen tests. Additionally, Hologic has pursued strategic mergers and acquisitions that have strengthened its product portfolio and market reach within the United States. By collaborating with healthcare institutions and investing in market expansion initiatives, Hologic has successfully positioned itself as a reliable provider of diagnostic tests, thus reinforcing its influence in the COVID testing landscape. ### **Key Companies in the US COVID Testing Kit Market Include** ## **US COVID Testing Kit Market Industry Developments** The US COVID Testing Kit Market has experienced significant developments recently, notably with Quidel Corporation actively expanding its product offerings, emphasizing innovative testing solutions. Hologic, in July 2023, announced an upgrade in its PCR testing capabilities, enhancing the speed and accuracy of COVID diagnostics. LabCorp continues to influence the market with initiatives focused on direct-to-consumer testing platforms, catering to rising public demand. During August 2023, Roche Diagnostics launched a new rapid antigen test, further bolstering its presence in the competitive landscape. In terms of mergers and acquisitions, Abbott Laboratories completed its acquisition of iRadimed Corporation in September 2023, enhancing its healthcare portfolio specifically targeted towards diagnostic technologies. Additionally, PerkinElmer has been in talks for strategic partnerships with diagnostics firms, reflecting its growth strategy amidst evolving market conditions. The market valuation of companies like Thermo Fisher Scientific and Cepheid has shown substantial growth, significantly impacting the overall landscape of the US COVID Testing Kit Market. Over the last two years, these companies have diversified their Product Development strategies to include new variants and testing modalities, responding dynamically to the ongoing health crisis while drawing insights from regulatory guidance and public health needs. ## **US COVID Testing Kit Market Segmentation Insights** ### **COVID Testing Kit Market Type Outlook** ### **COVID Testing Kit Market Specimen Outlook** ### **COVID Testing Kit Market End User Outlook** ## Market Drivers ### Emergence of New Variants The emergence of new variants continues to influence the dynamics of the covid testing-kit market. As variants evolve, the need for effective testing solutions that can accurately detect these strains becomes paramount. In 2025, the market sees a shift towards tests that are specifically designed to identify multiple variants, ensuring that public health measures remain effective. The covid testing-kit market is responding by investing in research and development to create more sophisticated testing technologies. This focus on variant detection is likely to drive sales, as healthcare providers and consumers seek reliable testing options. Moreover, the ongoing threat of new variants may lead to increased public awareness and demand for regular testing, further propelling market growth. ### Government Initiatives and Funding Government initiatives play a crucial role in shaping the covid testing-kit market. In 2025, federal and state governments have allocated substantial funding to enhance testing infrastructure and accessibility. This financial support is aimed at increasing the availability of testing kits, particularly in underserved communities. The covid testing-kit market benefits from these initiatives, as they facilitate partnerships between public health agencies and private manufacturers, leading to the development of affordable testing solutions. Additionally, government campaigns promoting regular testing have further stimulated market growth, with an estimated increase of 30% in testing kit distribution across various states. Such efforts underscore the importance of proactive testing in managing public health and controlling potential outbreaks. ### Increased Demand for Rapid Testing The covid testing-kit market experiences heightened demand for rapid testing solutions, driven by the need for quick results in various settings, including workplaces and schools. As organizations prioritize safety, the market for rapid antigen tests has surged, with sales reaching approximately $2 billion in 2025 alone. This trend indicates a shift towards immediate testing capabilities, allowing for timely decision-making and minimizing the spread of infections. The covid testing-kit market is adapting to this demand by innovating and expanding product lines to include more rapid testing options, which are essential for effective public health responses. Furthermore, the convenience of rapid tests is appealing to consumers, as they can be administered at home or in non-clinical environments, thus enhancing accessibility and encouraging widespread testing. ### Integration of Digital Health Solutions The integration of [digital health](https://www.marketresearchfuture.com/reports/digital-healthcare-market-7636) solutions into the covid testing-kit market is transforming how testing is conducted and managed. In 2025, many testing kits are now accompanied by mobile applications that facilitate result tracking and reporting. This technological advancement enhances user experience and encourages more individuals to participate in regular testing. The covid testing-kit market is witnessing a trend where digital platforms not only provide results but also offer guidance on next steps, such as isolation or vaccination. This integration is likely to improve overall public health outcomes by ensuring that individuals receive timely information. Furthermore, the data collected through these digital solutions can assist health authorities in monitoring trends and making informed decisions. ### Rising Consumer Awareness and Education Rising consumer awareness regarding the importance of testing is significantly impacting the covid testing-kit market. In 2025, educational campaigns aimed at informing the public about the benefits of regular testing have gained traction. This increased awareness is likely to lead to higher demand for testing kits, as individuals recognize their role in preventing the spread of infections. The covid testing-kit market is responding by enhancing marketing strategies to reach a broader audience, emphasizing the ease of use and accessibility of testing solutions. As consumers become more informed, they are more inclined to purchase testing kits for personal use, contributing to market growth. This trend suggests a shift towards a more proactive approach to health management among the general population. ## Future Outlook The [COVID Testing Kit Market](https://www.marketresearchfuture.com/reports/covid-testing-kit-market-9715) is projected to grow at a 7.55% CAGR from 2025 to 2035, driven by technological advancements, increased health awareness, and regulatory support. **New opportunities:** - Development of mobile testing units for remote areas. Integration of AI for rapid test result analysis. Expansion of subscription-based testing services for businesses. By 2035, the market is expected to be robust, driven by innovation and diverse service offerings. ## Segment Insights ### By Type: RT-PCR Assay Kits (Largest) vs. Immunoassay Test Strips (Fastest-Growing) In the US covid testing-kit market, RT-PCR Assay Kits dominate the market share due to their reliability and accuracy in detecting the virus. They are widely used in laboratories and healthcare facilities, accounting for a significant portion of the overall testing landscape. In contrast, Immunoassay Test Strips are gaining traction with their ease of use and quick results, appealing particularly to at-home testing and rapid diagnostics. The growth trends for these segments show that while RT-PCR kits maintain a strong presence, the demand for Immunoassay Test Strips is on the rise. This shift is driven by consumer preferences for convenience and the increasing race for quick results amidst ongoing testing needs. The flexibility and adaptability of both testing methods ensure they will continue to play crucial roles in the landscape. RT-PCR Assay Kits (Dominant) vs. Immunoassay Test Strips (Emerging) RT-PCR Assay Kits are recognized for their high sensitivity and specificity, making them the go-to choice for many healthcare providers in the US covid testing-kit market. Their performance in identifying active infections is unparalleled, thus reinforcing their dominant position. Conversely, Immunoassay Test Strips, although newer on the scene, are rapidly emerging as a preferred alternative due to their convenience and fast turnaround times. These strips offer users the ability to conduct tests at home or in non-laboratory settings, catering to an increasing demand for accessible and user-friendly testing solutions. The combination of these two segments reflects a diversified approach to covid testing, addressing various user needs effectively. ### By Specimen: Nasopharyngeal Swab (Largest) vs. Oropharyngeal Swab (Fastest-Growing) In the US covid testing-kit market, the distribution of market share among specimen types reveals that nasopharyngeal swabs hold the largest share due to their effectiveness in collecting respiratory specimens. Oropharyngeal and nasal swabs follow as significant alternatives, with oropharyngeal swabs gaining traction for their ease of collection and comfort for patients. Nasal swabs, being less invasive, appeal to a broader audience but still represent a smaller fraction of the market. Growth trends indicate an increasing preference for oropharyngeal swabs, which are emerging as the fastest-growing segment thanks to advancements in testing technology and heightened demand for user-friendly testing options. Factors such as the ongoing need for testing in various settings, including schools and travel, are driving innovation and adoption rates, making the segment highly competitive and dynamic in nature. Nasopharyngeal Swab (Dominant) vs. Nasal Swab (Emerging) Nasopharyngeal swabs are recognized as the dominant specimen type in the market due to their reliability and accuracy in detecting SARS-CoV-2. These swabs effectively collect samples from deep within the nasal cavity, allowing for a comprehensive analysis. On the other hand, nasal swabs are emerging as a preferred choice for many, primarily due to their less invasive nature and easier collection process, which appeals to patients who may be averse to the discomfort associated with deeper swabbing. As testing continues to evolve, both specimen types play crucial roles, with nasopharyngeal swabs maintaining a stronghold while nasal swabs position themselves as a convenient alternative. ### By End User: Hospitals and Clinics (Largest) vs. Diagnostic Laboratories (Fastest-Growing) In the US covid testing-kit market, Hospitals and Clinics dominate the end-user segment with significant market share. These institutions are pivotal to the healthcare infrastructure, being the primary access points for testing. Following closely are Diagnostic Laboratories, which are experiencing rapid growth owing to the increased demand for accurate and timely testing results. Other end-users, although contributing to the market, represent a smaller share than the leading segments. The growth trends in the US covid testing-kit market are significantly influenced by healthcare policies and the emphasis on early-stage testing in hospitals and clinics. As the focus on health awareness rises, there is a corresponding increase in demand for testing from Diagnostic Laboratories, which are innovating to provide results faster and more efficiently. The healthcare system's adaptability significantly aids in addressing the ongoing challenges posed by the pandemic. Hospitals and Clinics (Dominant) vs. Diagnostic Laboratories (Emerging) Hospitals and Clinics serve as the dominant players in the US covid testing-kit market, leveraging their established infrastructure to provide extensive testing services. Their comprehensive patient base and ability to integrate testing into routine health check-ups ensure a steady demand for testing kits. In contrast, Diagnostic Laboratories are emerging more robustly, capitalizing on technological advancements and the ability to process large volumes of tests rapidly. The growing trust in laboratory results, due to continuous innovations and high accuracy, positions these labs as critical players in public health strategies. Together, these segments illustrate a dynamic landscape that is responsive to the evolving needs of the healthcare sector. ## Competitive Benchmarking The covid testing-kit market exhibits a dynamic competitive landscape characterized by rapid innovation and strategic maneuvering among key players. Major companies such as Abbott Laboratories (US), Roche Diagnostics (CH), and Thermo Fisher Scientific (US) are at the forefront, each leveraging distinct strategies to enhance their market positioning. Abbott Laboratories (US) focuses on expanding its product portfolio through continuous innovation, particularly in rapid testing technologies, which has proven essential in meeting the evolving demands of healthcare providers. Meanwhile, Roche Diagnostics (CH) emphasizes strategic partnerships and collaborations to enhance its distribution capabilities, thereby ensuring a robust supply chain. Thermo Fisher Scientific (US) appears to be concentrating on digital transformation initiatives, integrating advanced data analytics into its testing solutions to improve accuracy and efficiency. The business tactics employed by these companies reflect a concerted effort to optimize operations and adapt to market demands. Localizing manufacturing has emerged as a critical strategy, allowing firms to mitigate supply chain disruptions and respond swiftly to regional needs. The market structure is moderately fragmented, with a mix of established players and emerging companies, each contributing to a competitive environment that fosters innovation and responsiveness. In October 2025, Abbott Laboratories (US) announced the launch of a new rapid antigen test designed to deliver results in under 15 minutes. This strategic move is significant as it positions Abbott to capture a larger share of the market, particularly in settings requiring immediate testing results, such as schools and workplaces. The introduction of this product aligns with the growing demand for quick and reliable testing solutions, thereby enhancing Abbott's competitive edge. In September 2025, Roche Diagnostics (CH) entered into a partnership with a leading [telehealth](https://www.marketresearchfuture.com/reports/telehealth-market-900)provider to integrate remote testing capabilities into its service offerings. This collaboration is noteworthy as it reflects Roche's commitment to expanding access to testing while leveraging technology to streamline the patient experience. By combining telehealth with diagnostic testing, Roche is likely to enhance its market presence and cater to the increasing preference for remote healthcare solutions. In August 2025, Thermo Fisher Scientific (US) unveiled a new AI-driven platform aimed at improving the accuracy of test results through advanced data analytics. This initiative underscores the company's focus on integrating cutting-edge technology into its operations, potentially setting a new standard for testing accuracy in the industry. The adoption of AI not only enhances operational efficiency but also positions Thermo Fisher as a leader in innovation within the market. As of November 2025, the competitive trends shaping the landscape include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly becoming a cornerstone of competitive strategy, enabling companies to pool resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve, with a greater emphasis on innovation and technological advancements rather than solely on price. The ability to ensure supply chain reliability while delivering cutting-edge solutions will likely define the future success of companies in this market. ## Recent News & Developments The US COVID Testing Kit Market has experienced significant developments recently, notably with Quidel Corporation actively expanding its product offerings, emphasizing innovative testing solutions. Hologic, in July 2023, announced an upgrade in its PCR testing capabilities, enhancing the speed and accuracy of COVID diagnostics. LabCorp continues to influence the market with initiatives focused on direct-to-consumer testing platforms, catering to rising public demand. During August 2023, Roche Diagnostics launched a new rapid antigen test, further bolstering its presence in the competitive landscape. In terms of mergers and acquisitions, Abbott Laboratories completed its acquisition of iRadimed Corporation in September 2023, enhancing its healthcare portfolio specifically targeted towards diagnostic technologies. Additionally, PerkinElmer has been in talks for strategic partnerships with diagnostics firms, reflecting its growth strategy amidst evolving market conditions. The market valuation of companies like Thermo Fisher Scientific and Cepheid has shown substantial growth, significantly impacting the overall landscape of the US COVID Testing Kit Market. Over the last two years, these companies have diversified their Product Development strategies to include new variants and testing modalities, responding dynamically to the ongoing health crisis while drawing insights from regulatory guidance and public health needs. ## Report Scope | MARKET SIZE 2024 | 19.84(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 21.34(USD Billion) | | MARKET SIZE 2035 | 44.18(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.55% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), BD (Becton, Dickinson and Company) (US), Siemens Healthineers (DE), Quidel Corporation (US), Cepheid (US), Hologic, Inc. (US), PerkinElmer, Inc. (US) | | Segments Covered | Type, Specimen, End User | | Key Market Opportunities | Integration of advanced diagnostics and telehealth solutions in the covid testing-kit market. | | Key Market Dynamics | Regulatory changes and technological advancements drive innovation and competition in the covid testing-kit market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US covid testing-kit market in 2024?** A: The market valuation was $19.84 Billion in 2024. **Q: What is the projected market valuation for the US covid testing-kit market in 2035?** A: The projected valuation for 2035 is $44.18 Billion. **Q: What is the expected CAGR for the US covid testing-kit market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.55% during the forecast period 2025 - 2035. **Q: Which segment had the highest valuation in the US covid testing-kit market in 2024?** A: The RT-PCR Assay Kits segment had the highest valuation at $10.0 Billion in 2024. **Q: What are the projected valuations for the Immunoassay Test Strips segment by 2035?** A: The projected valuation for the Immunoassay Test Strips segment is $13.0 Billion by 2035. **Q: Which specimen type is expected to show the highest growth in the US covid testing-kit market?** A: The Nasal Swab specimen type is expected to grow to $19.68 Billion by 2035. **Q: What was the market size for hospitals and clinics in the US covid testing-kit market in 2024?** A: The market size for hospitals and clinics was $7.93 Billion in 2024. **Q: What is the projected market size for diagnostic laboratories by 2035?** A: The projected market size for diagnostic laboratories is $14.36 Billion by 2035. **Q: Which key players are leading the US covid testing-kit market?** A: Key players include Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific. **Q: What was the valuation of the Others segment in the US covid testing-kit market in 2024?** A: The Others segment was valued at $5.46 Billion in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-covid-testing-kit-market-14626*